
Sign up to save your podcasts
Or
It’s a question of when, not if, highly effective treatments become available, says the CEO of Alzheimer’s Research UK. But that doesn’t solve the problem of one-third of dementia patients still going undiagnosed.
4.3
5656 ratings
It’s a question of when, not if, highly effective treatments become available, says the CEO of Alzheimer’s Research UK. But that doesn’t solve the problem of one-third of dementia patients still going undiagnosed.
6,241 Listeners
932 Listeners
760 Listeners
816 Listeners
424 Listeners
470 Listeners
408 Listeners
508 Listeners
100 Listeners
50 Listeners
60 Listeners
1,448 Listeners
127 Listeners
77 Listeners
254 Listeners
2,127 Listeners
505 Listeners